4.7 Article

Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood

期刊

BLOOD
卷 115, 期 9, 页码 1765-1767

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-09-241513

关键词

-

资金

  1. Tumorzentrum Heidelberg-Mannheim
  2. European Union (EU) [Food-CT-2005-016320, Health-F3-2007200767]
  3. Leukemia Research (United Kingdom)
  4. Kay Kendal Leukemia Fund
  5. Cancer Research United Kingdom [C1298/A8362]
  6. Bobby Moore Fund
  7. Deutsche Krebshilfe

向作者/读者索取更多资源

Recent genome-wide association data have implicated genetic variation at 7p12.2 (IKZF1), 10q21.2 (ARIDB5), and 14q11.2 (CEBPE) in the etiology of B-cell childhood acute lymphoblastic leukemia (ALL). To verify and further examine the relationship between these variants and ALL risk, we genotyped 1384 cases of precursor B-cell childhood ALL and 1877 controls from Germany and the United Kingdom. The combined data provided statistically significant support for an association between genotype at each of these loci and ALL risk; odds ratios (OR), 1.69 (P = 7.51 x 10(-22)), 1.80 (P = 5.90 x 10(-28)), and 1.27 (P = 4.90 x 10(-6)), respectively. Furthermore, the risk of ALL increases with an increasing numbers of variant alleles for the 3 loci (ORper-allele = 1.53, 95% confidence interval, 1.44-1.62; P-trend = 3.49 x 10(-42)), consistent with a polygenic model of disease susceptibility. These data provide unambiguous evidence for the role of these variants in defining ALL risk underscoring approximately 64% of cases. (Blood. 2010;115:1765-1767)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据